Workflow
Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Globenewswire· 2025-08-14 13:15
Company Overview - Senti Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation cell and gene therapies using its proprietary Gene Circuit platform [1][3] - The company aims to create new medicines that can precisely target and kill cancer cells while sparing healthy cells, enhancing specificity to target tissues, and allowing for control even after administration [3] Upcoming Presentation - Senti Bio will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech on August 19, 2025, at 2:20 PM ET [1] - The presentation will be led by Timothy Lu, M.D., Ph.D., Co-Founder and CEO of Senti Bio [1] Technology and Pipeline - Senti Bio's pipeline includes cell therapies engineered with Gene Circuits targeting challenging liquid and solid tumor indications [3] - The Gene Circuits have shown preclinical efficacy in both NK and T cells, with potential applications extending beyond oncology [3]
Wrap Technologies Unveils Second Counter-UAS Program: Handheld Surface-To-Air, Quick-Reaction Personal Anti-Drone Capability Repurposing BolaWrap 150
Globenewswire· 2025-08-14 13:15
Core Viewpoint - Wrap Technologies, Inc. has launched Project PAN-DA, a handheld counter-drone system derived from its BolaWrap® 150 platform, aimed at addressing the growing global counter-unmanned aircraft systems (C-UAS) market, projected to reach $6.8 billion by 2030 [1][6]. Company Overview - Wrap Technologies is a leader in innovative public safety technology, focusing on non-lethal tools and solutions for law enforcement and public safety organizations [14]. - The company has a proven track record with its BolaWrap® 150 device, which is used by over 1,000 law enforcement agencies worldwide [15]. Product Development - Project PAN-DA is designed to engage and disable small unmanned aerial systems (sUAS) at close range, providing a cost-effective and reusable alternative to traditional missile interceptors and electronic jamming systems [3][4]. - The system utilizes Wrap's patented tether-and-anchor technology, allowing for multiple engagements per unit, enhancing operational efficiency [3][4]. Market Context - The global counter-drone market is expected to grow from $1.9 billion in 2023 to over $6.8 billion by 2030, driven by the increasing use of small UAS in criminal and military activities [6]. - PAN-DA is positioned as a last-line kinetic defense option that complements existing detection and electronic countermeasure systems [6]. Research and Development - Following the successful proof of concept for Phase One, Wrap's engineering teams will focus on enhancing the system's range, area-of-effect, and cost-effectiveness to adapt to evolving drone threats [8].
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Globenewswire· 2025-08-14 13:15
Live video webcast on Wednesday, August 20th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as foll ...
AAGC Set to Launch New Concept
Globenewswire· 2025-08-14 13:15
LAS VEGAS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- All American Gold Corp. (OTC: AAGC) is delighted to update the public about the Company’s exciting new concept in the Beauty industry. Hollywood Star Cuts (A Family Salon) and All American Gold Corp. (AAGC) have finalized an agreement with a Franchise group based in San Diego, CA, to launch a concept that will complement the proven Hollywood Star Cuts model in exclusive areas. Hollywood Star Salons is an exciting new platform set to debut in October 2025 in Encin ...
North Media upgrades its full-year EBITDA and EBIT guidance based on preliminary financial results for the second quarter of 2025.
Globenewswire· 2025-08-14 13:12
Core Insights - North Media reported Q2 2025 revenue of DKK 342 million, slightly down from DKK 343 million in Q2 2024, with a stable trend in Last Mile services and a 2% increase in Digital Services driven by BoligPortal [1] - The company has revised its full-year revenue guidance for 2025 to DKK 1,270–1,315 million, down from the previous range of DKK 1,280–1,337 million, while EBITDA and EBIT guidance has been upgraded [2][5] - The improvement in EBITDA and EBIT is primarily due to enhanced operations at SDR, leading to more stable planning and lower unit costs, with Bekey also contributing positively [3] Financial Performance - Q2 2025 EBITDA was DKK 48 million, down from DKK 61 million in Q2 2024, and EBIT was DKK 32 million compared to DKK 44 million in the previous year [1] - The revised guidance for 2025 includes EBITDA expectations of DKK 105–130 million, up from DKK 80–115 million, and EBIT expectations of DKK 50–75 million, up from DKK 25–60 million [2][5] Business Segments - North Media operates in two main business areas: Last Mile, which includes FK Distribution and SDR Svensk Direktreklam, and Digital Services, which encompasses BoligPortal, Dayli (MineTilbud), and Bekey [7] - The Last Mile segment is experiencing a slight loss in volumes, while growth in Digital Services, particularly BoligPortal and Dayli, has been lower than expected [4]
Fairfax Completes C$700 Million Senior Notes Offering
Globenewswire· 2025-08-14 13:05
Core Viewpoint - Fairfax Financial Holdings Limited has successfully completed an offering of C$400 million in 4.45% Senior Notes due 2035 and C$300 million in 5.10% Senior Notes due 2055, totaling C$700 million in Senior Notes [1][2]. Group 1: Offering Details - The Senior Notes were offered through a syndicate of dealers led by National Bank Financial Inc., RBC Dominion Securities Inc., Scotia Capital Inc., and TD Securities Inc. as joint bookrunners [2]. - The Senior Notes are unsecured obligations of Fairfax [2]. Group 2: Use of Proceeds - Fairfax intends to use the net proceeds from the offering to refinance, repay, or redeem outstanding debt, equity, or other corporate obligations, pursue potential acquisition or investment opportunities, and for general corporate purposes [3]. - Specific determinations regarding the debt, equity, or corporate obligations to be repaid or redeemed have not yet been made, nor have decisions been made regarding specific acquisitions or investments [3]. Group 3: Company Overview - Fairfax is a holding company primarily engaged in property and casualty insurance and reinsurance, along with associated investment management [5].
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
Globenewswire· 2025-08-14 13:05
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial results after market close on Thursday, August 28, 2025. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the start of t ...
XBP Global Holdings, Inc. Reports Second Quarter 2025 Results
Globenewswire· 2025-08-14 13:03
Second Quarter 2025 Highlights XBP Europe Holdings, Inc. (“XBP Europe”) completed the acquisition of Exela Technologies BPA, LLC (“BPA”) and changed its name to XBP Global Holdings, Inc. Revenue of $39.6 million, an increase of 17.8% year-over-year and 5.2% sequentiallyGross margin of 29.8%, a 1,020 bps increase year-over-year and 30 bps decrease sequentially Adjusted EBITDA of $3.3 million, an increase of 173.8% year-over-year and decrease of 11.2% sequentially IRVING, Texas and LONDON, Aug. 14, 2025 (GLOB ...
Last patient visit completed on schedule in Phase 1b clinical trial of HER-096 for Parkinson’s disease
Globenewswire· 2025-08-14 13:02
Patient visits are now complete in the final cohort of Phase 1b trial, consisting of Parkinson’s disease patients receiving 300 mg doses of HER-096 or placebo twice weekly over a four-week periodPrimary objective is to assess the safety, tolerability and pharmacokinetics of repeated subcutaneous doses of HER-096; the trial will also evaluate selected biomarkers, and aims to identify novel treatment response biomarkers and monitor symptoms associated with Parkinson’s diseaseTopline Phase 1b results are expec ...
Norsk Hydro: Hydro cuts costs and carries out strategic workforce adjustment
Globenewswire· 2025-08-14 12:58
Core Viewpoint - Hydro is initiating a process to cut annual costs by NOK 1 billion, which includes reducing its workforce by 750 positions to strengthen long-term resilience and adapt to changing business requirements [1][2]. Cost Reduction Measures - The company plans to reduce its capital expenditure estimate for 2025 from NOK 15 billion to NOK 13.5 billion as part of its improvement program [2]. - The cost-cutting measures will include reducing travel and consultancy costs, alongside workforce adjustments [1][2]. Workforce Adjustments - Hydro will reduce approximately 750 white-collar positions, with 600 full-time equivalents (FTEs) expected to be cut by the end of 2025 and an additional 150 to be identified through efficiency initiatives from 2026 onwards [3][5]. - The workforce adjustments will primarily affect white-collar roles, including staff and support functions, engineering, commercial, supply chain, and IT, while blue-collar positions will remain unaffected [5]. Commitment to Transparency - The company is committed to conducting the transition with transparency and care, ensuring collaboration with employee representatives throughout the process [4][6]. - Hydro's approach is guided by its values of care, courage, and collaboration [4]. Long-term Value Delivery - By implementing these measures, Hydro aims to enhance its ability to navigate uncertainty and continue delivering long-term value to customers, employees, and stakeholders [6].